SymphoRNA

Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)

Operator of a novel cultivated-protein production process designed to create animal-cell-derived meat without conventional livestock. SymphoRNA is based in Cambridge, United Kingdom and was founded in 2017. Its last known valuation is $98.4 million. It has raised $49.2 million.

Last price · $/share

—

Implied valuation

$98.4M

Total raised

$49.2M

Last round

—

How much has SymphoRNA raised?

$49.2Macross 0 recorded rounds

Free account

More of SymphoRNA with a free account

·The complete investor list: 22 names
·Watch SymphoRNA: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

SymphoRNA investors

22 investors are on record for SymphoRNA, including Global Brain, MicroVentures, Lowercarbon Capital and Balderton Capital. By type, the record holds 5 venture capital firms and 1 hedge fund.

For fundraisers

Raising for a company like SymphoRNA?

22 investors have backed SymphoRNA.

See all 22 investors →

Frequently asked about SymphoRNA

How much has SymphoRNA raised?: SymphoRNA has raised $49.2M in total across 0 recorded funding rounds.